T. Shaw3, L.; Hariprasad, I.; V. Messner, L.; A. Bansal, C.; A. Schechet, S.; Pérez, J. Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature. BOHR International Journal of Current Research in Optometry and Ophthalmology 2022, 1, 74–79.